BridgeBio Pharma
BBIO
BBIO
129 hedge funds and large institutions have $4.39B invested in BridgeBio Pharma in 2020 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 36 increasing their positions, 48 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
129
Holders Change
+13
Holders Change %
+11.21%
% of All Funds
2.61%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.18%
New
26
Increased
36
Reduced
48
Closed
13
Calls
$2.89M
Puts
$1.83M
Net Calls
+$1.05M
Net Calls Change
-$23.7M
Top Buyers
| 1 |
1
BlackRock
New York
|
$230M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$236M |
| 3 |
3
Norges Bank
Oslo,
Norway
|
$21.5M |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$43.5M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$48.4M |
